Browse studies

Find your next paid study

53 recruiting studies matching your filters

Phase 1/2 Study: CD45RA Depleted Peripheral Stem Cell Addback to Prevent Viral and Fungal Infections Following Alternative Donor TCRab/CD19 Depleted Hematopoietic Stem Cell Transplant

The major morbidities of allogeneic hematopoietic stem cell transplant (HSCT) using donors that are not human leukocyte antigen (HLA) matched siblings are graf…

LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more

Estimated

~$10 – $6,250

Children's Hospital of PhiladelphiaNCT06839456

Phase 2

Safety and Immunogenicity of Shingrix Administered to Recipients of Allogeneic Peripheral and Cord Blood Stem Cell Transplants: Effect of Timing of Vaccination After Transplantation

This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity an…

Bone Marrow TransplantStem Cell Transplant

Estimated

~$10 – $6,250

University of Colorado, DenverNCT05775718

Phase 2

A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation

The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), doubl…

Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more

Estimated

~$10 – $7,500

Paul SzabolcsNCT01962415

Activity Levels in Bone Marrow Transplant Patients

Participants in this study will be receiving a bone marrow transplant. This study is designed to evaluate correlations between activity levels and length of st…

Bone Marrow Transplant

Estimated

~$10 – $1,125

Michael TomassonNCT04115241

Phase 1

Expanded Access Protocol Using CD3+/CD19+ Depleted Unrelated Donor or Related Donor Peripheral Stem Cells

The goal of this protocol is to expand access for patients who lack a fully HLA (Human leukocyte antigen) matched sibling donor and who are candidates for allo…

LeukemiaInborn Errors of MetabolismBone Marrow Failure Syndromes+2 more

Estimated

~$10 – $6,250

Children's Hospital of PhiladelphiaNCT02356653